Similarly, Karouni et al. described that pDCs are present in 90% of cases of Kaposi's sarcoma (KS), with reduced MxA expression, indicating suppression by Kaposi's sarcoma-associated herpesvirus (KSHV), through viral proteins that would inhibit the signaling pathways of pDCs activation. Here, MX1 is linked to Kaposi's sarcoma.